88), in favor of CEA for patients aged 65
to 69 years and an HR of 2.09 (95% CI, 1.32-3.32) for patients aged 70 to 74 years.37 If octogenarians (>80 years)
were removed from the data to allow the CREST Ô¨Åndings
to be compared with those from other trials in which such
patients were not enrolled